This trial is active, not recruiting.

Condition graft vs host disease
Treatment high dose chemo and auto hematopoietic cell transplant
Phase phase 2
Sponsor Stanford University
End date March 2005
Trial identifier NCT00186641, BMT42


To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model single group assignment
Masking open label
Primary purpose treatment

Primary Outcomes

time frame:

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - Stage II, III or IV breast cancer - chemosensitive - adequate organ function Exclusion Criteria: - prior transplant, - life threatening disease - brain metastases

Additional Information

Official title High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer
Principal investigator Ginna Laport, MD
Trial information was received from ClinicalTrials.gov and was last updated in July 2007.
Information provided to ClinicalTrials.gov by Stanford University.